CONCERN: Does ovary need D-chiro-inositol?
Open Access
- 15 May 2012
- journal article
- Published by Springer Science and Business Media LLC in Journal of Ovarian Research
- Vol. 5 (1), 14-5
- https://doi.org/10.1186/1757-2215-5-14
Abstract
Backgroud Polycystic Ovary Syndrome (PCOS) is a multifactorial pathology that affects 10% of the women in reproductive age being the main cause of infertility due to menstrual dysfunction. Since 1980, it is known that PCOS is associated with insulin resistance (IR). The recognition of this association has prompted extensive investigation on the relationship between insulin and gonadal function, and has turned insulin sensitizer agent as the main therapeutic choice. In particular two different polyalcohol myo-inositol and D-chiro-inositol have been shown to improve insulin resistance, hyperandrogenism and to induce ovulation in PCOS women. In particular, while data on myo-inositol and restored ovulation were consistent, data on D-chiro-inositol were not . Recently, a comparative study, proposed a D-chiro-inositol paradox in the ovary of PCOS patients hypothesizing that only myo-inositol has a specific ovarian action. In the present study we aim to further study the role played by D-chiro-inositol at ovarian level. Methods A total of 54 women, aged <40 years and diagnosed with PCOS were enrolled in this study. Patients with insulin resistance and/or hyperglycaemia were excluded from the study. Patients were randomly divided into 5 groups (n=10-12): a placebo group, and 4 groups (A-D) that received 300-600-1200-2400 mg of DCI daily respectively. All treatments were carried out for 8 weeks before follicle stimulating hormone (rFSH) administration. Results Total r-FSH units increased significantly in the two groups that received the higher doses of DCI. The number of immature oocytes was significantly increased in the three groups that received the higher doses of DCI. Concurrently, the number of MII oocytes was significantly lower in the D group compared to placebo group. Noteworthy, the number of grade I embryos was significantly reduced by DCI supplementation. Conclusions Indeed, increasing DCI dosage progressively worsens oocyte quality and ovarian response.Keywords
This publication has 34 references indexed in Scilit:
- Oocyte quality reflected by follicular fluid analysis in poly cystic ovary syndrome (PCOS): A hypothesis based on intermediates of energy metabolismMedical Hypotheses, 2012
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS womenGynecological Endocrinology, 2009
- Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trialFertility and Sterility, 2009
- Insulin-stimulated release of d-chiro-inositol–containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndromeMetabolism, 2008
- Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivityFertility and Sterility, 2007
- Proteomic analysis of human ovaries from normal and polycystic ovarian syndromeMolecular Human Reproduction, 2007
- Current Approaches to the Diagnosis and Treatment of Polycystic Ovarian Syndrome in YouthHormone Research in Paediatrics, 2007
- Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation inductionGynecological Endocrinology, 2007
- Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary SyndromeThe New England Journal of Medicine, 1999
- Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivoEndocrinology, 1993